Cardiol Therapeutics (CRDL) News Today C$1.76 +0.04 (+2.33%) As of 01/17/2025 04:34 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Cardiol Therapeutics (TSE:CRDL) Shares Down 3.4% - Here's What HappenedCardiol Therapeutics (TSE:CRDL) Shares Down 3.4% - What's Next?January 17 at 2:40 AM | marketbeat.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Acquires 17,240 Shares of StockDecember 27, 2024 | insidertrades.comCardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Guillermo Torre Buys 17,240 SharesCardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Senior Officer Guillermo Torre bought 17,240 shares of the stock in a transaction that occurred on Thursday, December 26th. The shares were bought at an average cost of C$1.81 per share, with a total value of C$31,277.77.December 26, 2024 | marketbeat.comAndrew Warwick Hamer Purchases 18,900 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockDecember 25, 2024 | insidertrades.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Purchases 18,900 Shares of StockCardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Senior Officer Andrew Warwick Hamer bought 18,900 shares of Cardiol Therapeutics stock in a transaction on Thursday, December 19th. The stock was purchased at an average price of C$1.88 per share, with a total value of C$35,606.69.December 24, 2024 | marketbeat.comVernon Bernardino Issues Buy Rating on Cardiol Therapeutics Following Promising Clinical Results and Strong Financial PositionDecember 19, 2024 | markets.businessinsider.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Purchases 10,000 Shares of StockCardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Senior Officer Bernard Lim bought 10,000 shares of the stock in a transaction that occurred on Tuesday, December 17th. The stock was acquired at an average price of C$1.95 per share, for a total transaction of C$19,500.00.December 17, 2024 | marketbeat.comDavid Elsley Buys 40,000 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockCardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Director David Elsley purchased 40,000 shares of the firm's stock in a transaction on Monday, December 16th. The shares were purchased at an average cost of C$1.88 per share, for a total transaction of C$75,072.00.December 17, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Down 2.1% - Here's What HappenedCardiol Therapeutics (TSE:CRDL) Trading Down 2.1% - What's Next?December 14, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 1.8% - Here's What HappenedCardiol Therapeutics (TSE:CRDL) Shares Up 1.8% - Here's WhyNovember 22, 2024 | marketbeat.comCBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical StudyNovember 19, 2024 | benzinga.comCardiol Therapeutics added to PRISM Emerging Biotech IndexNovember 13, 2024 | markets.businessinsider.comCardiol Therapeutics (TSE:CRDL) Shares Down 0.8% - Should You Sell?Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.8% - Should You Sell?October 31, 2024 | marketbeat.comCardiol Therapeutics Expands Trials for Heart TreatmentOctober 22, 2024 | markets.businessinsider.comWhy Cardiol Therapeutics (CRDL) Stock Is Down 20% TodayOctober 9, 2024 | benzinga.comCardiol Therapeutics (TSE:CRDL) Trading Down 19.7% - Here's What HappenedCardiol Therapeutics (TSE:CRDL) Shares Down 19.7% - Time to Sell?October 9, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Up 1.1%Cardiol Therapeutics (TSE:CRDL) Trading 1.1% HigherSeptember 27, 2024 | marketbeat.comCardiol Therapeutics to present Phase II study resultsSeptember 12, 2024 | uk.investing.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 0.8%Cardiol Therapeutics (TSE:CRDL) Trading Up 0.8%September 5, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 3.6%Cardiol Therapeutics (TSE:CRDL) Shares Up 3.6%August 14, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 1.6%Cardiol Therapeutics (TSE:CRDL) Trading Up 1.6%July 23, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Down 0.7%Cardiol Therapeutics (TSE:CRDL) Shares Down 0.7%July 16, 2024 | marketbeat.comDavid Elsley Acquires 50,000 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockJune 25, 2024 | insidertrades.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Director Purchases 50,000 Shares of StockCardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Director David Elsley bought 50,000 shares of the business's stock in a transaction that occurred on Monday, June 24th. The shares were bought at an average cost of C$2.77 per share, for a total transaction of C$138,490.00.June 24, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Shares Up 11.7%Cardiol Therapeutics (TSE:CRDL) Trading 11.7% HigherJune 10, 2024 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Cardiol Therapeutics (CRDL) and MicroPort Scientific (OtherMCRPF)May 14, 2024 | markets.businessinsider.comManufacturing, Housing Due Next Week in CanadaMay 10, 2024 | baystreet.caCardiol Therapeutics (TSE:CRDL) Trading 12.9% Higher Cardiol Therapeutics (TSE:CRDL) Stock Price Up 12.9%April 30, 2024 | marketbeat.comBuy Rating on Cardiol Therapeutics: Projected Blockbuster CardiolRx’s Strategic Advantages and Market PotentialApril 23, 2024 | markets.businessinsider.comClosing Bell: Cardiol Therapeutics Inc Purchase WT up on Tuesday (CRDL-WT-A)April 20, 2024 | theglobeandmail.comCRDL:CA Cardiol Therapeutics Inc.April 13, 2024 | seekingalpha.comCardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent PericarditisFebruary 21, 2024 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Monday (CRDL-WT-A)February 9, 2024 | theglobeandmail.comIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?February 2, 2024 | finance.yahoo.comCardiol Therapeutics Inc Class AJanuary 30, 2024 | morningstar.comCardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-PilotDecember 5, 2023 | finance.yahoo.comCardiol Therapeutics reaches new milestone in Phase II study for recurrent pericarditisNovember 1, 2023 | proactiveinvestors.comCardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent PericarditisNovember 1, 2023 | finance.yahoo.comCardiol Therapeutics Inc.: Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementOctober 23, 2023 | finanznachrichten.deCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart DiseasesOctober 13, 2023 | finance.yahoo.comCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart DiseasesOctober 13, 2023 | finance.yahoo.comCardiol Therapeutics releases positive study results of...Cardiol Therapeutics releases positive study results of...October 11, 2023 | proactiveinvestors.comCBD To Treat Heart Failure? New Study Shows Its Cardioprotective EffectsOctober 10, 2023 | benzinga.comCardiol Therapeutics Inc.: Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare ConferenceSeptember 28, 2023 | finanznachrichten.deCardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare ConferenceSeptember 26, 2023 | finance.yahoo.comCardiol Therapeutics on track to complete enrollment for acute myocarditis trial six months ahead of scheduleSeptember 19, 2023 | proactiveinvestors.comCardiol Therapeutics Inc. (CRDL) Upgraded to Buy: Here's What You Should KnowAugust 16, 2023 | msn.comCRDL.TO - Cardiol Therapeutics Inc.June 6, 2023 | finance.yahoo.comCardiol Therapeutics (CRDL) Earnings Dates & ReportsMay 19, 2023 | investing.comClosing Bell: Cardiol Therapeutics Inc down on Monday (CRDL)May 9, 2023 | theglobeandmail.com Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRDL Media Mentions By Week CRDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼1.110.57▲Average Medical News Sentiment CRDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼10▲CRDL Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aimia News Fennec Pharmaceuticals News Andean Precious Metals News International Tower Hill Mines News Gear Energy News Graphite One News Medicenna Therapeutics News EQ News CI Canadian Convertible Bond ETF Common News Moneta Gold News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CRDL) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
